Search Results - "Goldenberg, S.L"

Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret by Aning, J J, Wassersug, R J, Goldenberg, S L

“…The number of prostate cancer survivors is rapidly growing in the Western world. As a result of better oncologic outcomes, more patients are living longer with…”
Get full text

Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy by Klotz, L H, Goldenberg, S L, Jewett, M A, Fradet, Y, Nam, R, Barkin, J, Chin, J, Chatterjee, S

“…In 1992 we initiated a national randomized prospective trial of 3 months of cyproterone acetate before radical prostatectomy compared to prostatectomy alone…”
Get more information

30 Active surveillance in 853 men with low and intermediate risk prostate cancer by Aning, J.J, Peacock, M, Zargar, H, McKenzie, M, Black, P.B, So, A.I, Goldenberg, S.L, Gleave, M.E

Get full text

959 The role of multi-parametric MRI in the management of patients on active surveillance for prostate cancer by Abdi, H, Walshe, T, Pourmalek, F, Aning, J.J, Zargar, H, Harris, A.C, Chang, S.D, So, A.I, Gleave, M.E, Machan, L, Black, P.C, Goldenberg, S.L

Get full text

1093 An international multi-center study examining re-classification rates of patients with prostate cancer suitable active surveillance whom underwent radical prostatectomy by Wong, L.M, Johnston, R, Neal, D.E, Warren, A, Shah, N, Hovens, C, Goldenberg, S.L, Gleave, M.E, Costello, A.J, Corcoran, N.M

Get full text

587 PROSTATE BIOPSY ANTISEPSIS CLINICAL TRIAL: A REPORT ON THE FIRST 500 PATIENTS by Abughosh, Z.M.N, Margolick, J.F, Goldenberg, S.L, Afshar, K, Taylor, S, Lange, D, Chew, B.H, Gleave, M.E, So, A.I, McLoughlin, M.G, Bowie, W.R, Roscoe, D.L, Machan, L.S, Balck, P.C

Get full text

Patients’ preferences for communicating a prostate cancer diagnosis and participating in medical decision‐making by Davison, B.J., Parker, P.A., Goldenberg, S.L.

“…OBJECTIVES To assess patients’ preferences about how physicians’ deliver news of a prostate cancer diagnosis, and patients’ preferred participation in medical…”
Get full text

Decisional regret and quality of life after participating in medical decision‐making for early‐stage prostate cancer by Davison, B.J., Goldenberg, S.L.

“…OBJECTIVE To determine the effect of men's reported levels of involvement in medical decision‐making and quality of life (QoL) on their levels of decisional…”
Get full text

Intermittent versus continuous androgen suppression therapy: do we have consensus yet? by Buchan, N C, Goldenberg, S L

“…Androgen deprivation therapy (ADT) has been a cornerstone in the management of advanced prostate cancer for more than 50 years, but several aspects of the…”
Get full text

Intermittent androgen suppression by Pether, M., Goldenberg, S.L.

Get full text

Preferences for sexual information resources in patients treated for early‐stage prostate cancer with either radical prostatectomy or brachytherapy by Davison, B.J., Keyes, M., Elliott, S., Berkowitz, J., Goldenberg, S.L.

“…OBJECTIVE To identify the preferences for sexual information resources of patients before and after definitive treatment for early‐stage prostate cancer with…”
Get full text

Intermittent androgen suppression for prostate cancer: rationale and clinical experience by Gleave, M, Bruchovsky, N, Goldenberg, S L, Rennie, P

“…The rationale behind intermittent androgen suppression (IAS) is based on: (1) observations that androgen ablation is palliative, not curative, in most patients…”
Get more information

29 A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of OGX-011, a 2′-methoxyethyl phosphorothioate antisense to clusterin, in patients with prostate cancer prior to radical prostatectomy by Chi, K.N., Eisenhauer, E., Fazli, L., Jones, E.C., Powers, J., Hurtado-Coll, A., Goldenberg, S.L., Gleave, M.E.

Get full text

Re: Editorial comment by Goldenberg, S L, Gleave, M E, Bruchovsky, N, Rennie, P

Get more information

Transurethral electrovaporization of the prostate versus transurethral prostatic resection: a comparison of postoperative hemorrhage by Chow, V.D.W., Sullivan, L.D., Wright, J.E., Goldenberg, S.L., Fenster, H.N., Gleave, M.E., McLoughlin, M.G.

“…Objectives. To determine the acute and delayed hemorrhage rate of transurethral electrovaporization of the prostate (TEVP) versus standard transurethral…”
Get full text

Low-dose cyproterone acetate plus mini-dose diethylstilbestrol—A protocol for reversible medical castration by Goldenberg, S.L., Bruchovsky, N., Gleave, M.E., Sullivan, L.D.

“…To determine whether a low dose of cyproterone acetate (CPA) (50 mg twice a day) with minidose diethystilbestrol (DES) is efficacious in rapidly reducing and…”
Get full text

Neoadjuvant androgen deprivation therapy before radical prostatectomy: who is unlikely to benefit? by Rabbani, F., Sullivan, L.D., Goldenberg, S.L., Stothers, L.

“…Objective To determine which patients undergoing radical prostatectomy for localized cancer are unlikely to benefit from neoadjuvant androgen withdrawal…”
Get full text

Transurethral resection of prostatic abscess under sonographic guidance by Kinahan, T J, Goldenberg, S L, Ajzen, S A, Cooperberg, P L, English, R A

“…Transrectal ultrasound may establish the diagnosis of prostatic abscess in an ambiguous clinical setting. Transurethral resection (deroofing) is the treatment…”
Get more information

Disseminated intravascular coagulation in carcinoma of prostate: role of estrogen therapy by Goldenberg, S L, Fenster, H N, Perler, Z, McLoughlin, M G

“…Advanced carcinoma of the prostate may present as disseminated intravascular coagulation and its sequelae. It is postulated that the slow release of…”
Get more information

Female bladder neck reconstruction. Anatomic and physiologic approach by Goldenberg, S L, Fenster, H, McLoughlin, M G

“…Postoperative scarring of the bladder neck and urethra after failed anti-incontinence surgery in the female can seriously disrupt the normal mechanisms of…”
Get more information